These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 26819957)

  • 1. Towards Targeted Delivery Systems: Ligand Conjugation Strategies for mRNA Nanoparticle Tumor Vaccines.
    Phua KK
    J Immunol Res; 2015; 2015():680620. PubMed ID: 26819957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.
    Rosalia RA; Cruz LJ; van Duikeren S; Tromp AT; Silva AL; Jiskoot W; de Gruijl T; Löwik C; Oostendorp J; van der Burg SH; Ossendorp F
    Biomaterials; 2015 Feb; 40():88-97. PubMed ID: 25465442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting human dendritic cells via DEC-205 using PLGA nanoparticles leads to enhanced cross-presentation of a melanoma-associated antigen.
    Saluja SS; Hanlon DJ; Sharp FA; Hong E; Khalil D; Robinson E; Tigelaar R; Fahmy TM; Edelson RL
    Int J Nanomedicine; 2014; 9():5231-46. PubMed ID: 25419128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-Based Vaccines in Cancer Immunotherapy.
    McNamara MA; Nair SK; Holl EK
    J Immunol Res; 2015; 2015():794528. PubMed ID: 26665011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studies.
    Diken M; Kreiter S; Selmi A; Türeci O; Sahin U
    Methods Mol Biol; 2013; 969():235-46. PubMed ID: 23296938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in dendritic cell-based vaccine of cancer.
    Zhang X; Gordon JR; Xiang J
    Cancer Biother Radiopharm; 2002 Dec; 17(6):601-19. PubMed ID: 12537664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Messenger RNA (mRNA) nanoparticle tumour vaccination.
    Phua KK; Nair SK; Leong KW
    Nanoscale; 2014 Jul; 6(14):7715-29. PubMed ID: 24904987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo.
    Qiu J; Lil GW; Sui YF; Sun YJ; Huang YY; Si SY; Ge W; Song HP
    Hepatogastroenterology; 2007; 54(75):681-7. PubMed ID: 17591041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges and advances towards the rational design of mRNA vaccines.
    Pollard C; De Koker S; Saelens X; Vanham G; Grooten J
    Trends Mol Med; 2013 Dec; 19(12):705-13. PubMed ID: 24138818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable lipophilic polymeric mRNA nanoparticles for ligand-free targeting of splenic dendritic cells for cancer vaccination.
    Ben-Akiva E; Karlsson J; Hemmati S; Yu H; Tzeng SY; Pardoll DM; Green JJ
    Proc Natl Acad Sci U S A; 2023 Jun; 120(26):e2301606120. PubMed ID: 37339211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing tumor specific immune responses by transcutaneous vaccination.
    Saliba H; Heurtault B; Bouharoun-Tayoun H; Flacher V; Frisch B; Fournel S; Chamat S
    Expert Rev Vaccines; 2017 Nov; 16(11):1079-1094. PubMed ID: 28937293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
    Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
    Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor vaccination using messenger RNA: prospects of a future therapy.
    Kreiter S; Diken M; Selmi A; Türeci Ö; Sahin U
    Curr Opin Immunol; 2011 Jun; 23(3):399-406. PubMed ID: 21497074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting myeloid cells using nanoparticles to improve cancer immunotherapy.
    Amoozgar Z; Goldberg MS
    Adv Drug Deliv Rev; 2015 Aug; 91():38-51. PubMed ID: 25280471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination.
    Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K
    Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient antigen gene transduction using Arg-Gly-Asp fiber-mutant adenovirus vectors can potentiate antitumor vaccine efficacy and maturation of murine dendritic cells.
    Okada N; Saito T; Masunaga Y; Tsukada Y; Nakagawa S; Mizuguchi H; Mori K; Okada Y; Fujita T; Hayakawa T; Mayumi T; Yamamoto A
    Cancer Res; 2001 Nov; 61(21):7913-9. PubMed ID: 11691812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy.
    Xiang J; Xu L; Gong H; Zhu W; Wang C; Xu J; Feng L; Cheng L; Peng R; Liu Z
    ACS Nano; 2015 Jun; 9(6):6401-11. PubMed ID: 26028363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy.
    Neill B; Romero AR; Fenton OS
    ACS Appl Bio Mater; 2024 Aug; 7(8):4894-4913. PubMed ID: 37930174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient nontoxic delivery of PD-L1 and PD-L2 siRNA into dendritic cell vaccines using the cationic lipid SAINT-18.
    Roeven MW; Hobo W; van der Voort R; Fredrix H; Norde WJ; Teijgeler K; Ruiters MH; Schaap N; Dolstra H
    J Immunother; 2015 May; 38(4):145-54. PubMed ID: 25839440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor antigens to dendritic cells using particulate carriers.
    Joshi MD; Unger WJ; Storm G; van Kooyk Y; Mastrobattista E
    J Control Release; 2012 Jul; 161(1):25-37. PubMed ID: 22580109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.